Editorial
doi: 10.1093/cid/ciu123.
Epub 2014 Feb 27.
Editorial commentary: Risks and benefits of tenofovir in the context of kidney dysfunction in sub-Saharan Africa
Affiliations
- PMID: 24585560
- PMCID: PMC4001289
- DOI: 10.1093/cid/ciu123
Item in Clipboard
Editorial
Editorial commentary: Risks and benefits of tenofovir in the context of kidney dysfunction in sub-Saharan Africa
Clin Infect Dis.
2014 May.
No abstract available
Keywords: HIV; kidney disease; sub-Saharan Africa; tenofovir.
Comment on
-
Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.Clin Infect Dis. 2014 May;58(10):1473-80. doi: 10.1093/cid/ciu117. Epub 2014 Feb 27. Clin Infect Dis. 2014. PMID: 24585558 Free PMC article.
Similar articles
-
Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.Clin Infect Dis. 2014 May;58(10):1473-80. doi: 10.1093/cid/ciu117. Epub 2014 Feb 27. Clin Infect Dis. 2014. PMID: 24585558 Free PMC article.
-
Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.Trop Med Int Health. 2015 Apr;20(4):518-26. doi: 10.1111/tmi.12446. Epub 2014 Dec 12. Trop Med Int Health. 2015. PMID: 25442109
-
How does weight influence tenofovir disoproxil-fumarate induced renal function decline?AIDS. 2015 Mar 13;29(5):643-5. doi: 10.1097/QAD.0000000000000577. AIDS. 2015. PMID: 25710292 No abstract available.
-
Tenofovir-associated nephrotoxicity in two HIV-infected adolescent males.AIDS Patient Care STDS. 2009 Jan;23(1):1-4. doi: 10.1089/apc.2008.0106. AIDS Patient Care STDS. 2009. PMID: 19183077 Review.
-
Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments.Curr HIV/AIDS Rep. 2016 Jun;13(3):149-57. doi: 10.1007/s11904-016-0315-y. Curr HIV/AIDS Rep. 2016. PMID: 27130284 Review.
Cited by
-
Factors Associated with Antiretroviral Therapy Toxicity Out-Comes in Patients with and without Hypertension.Int J Environ Res Public Health. 2022 Sep 3;19(17):11051. doi: 10.3390/ijerph191711051. Int J Environ Res Public Health. 2022. PMID: 36078765 Free PMC article.
-
Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population.CPT Pharmacometrics Syst Pharmacol. 2023 Jun;12(6):821-830. doi: 10.1002/psp4.12955. Epub 2023 Apr 4. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37013631 Free PMC article. Clinical Trial.
-
Longitudinal Progression of Estimated GFR in HIV-1-Infected Patients with Normal Renal Function on Tenofovir-Based Therapy in China.Ther Clin Risk Manag. 2020 Apr 17;16:299-310. doi: 10.2147/TCRM.S243913. eCollection 2020. Ther Clin Risk Manag. 2020. PMID: 32368069 Free PMC article.
-
Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens.AIDS. 2016 May 15;30(8):1221-8. doi: 10.1097/QAD.0000000000001041. AIDS. 2016. PMID: 26836786 Free PMC article.
-
Renal outcomes in adults with HBV, HIV and HBV/HIV coinfection after 3 years of antiviral therapy in urban Tanzania.J Antimicrob Chemother. 2024 Jan 3;79(1):36-45. doi: 10.1093/jac/dkad341. J Antimicrob Chemother. 2024. PMID: 37935111 Free PMC article.
References
-
- Cooper RD, Wiebe N, Smith N, Keiser P, Naicker S, Tonelli M. Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis. 2010;51:496–505. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
